Trial · NCT03252249
Trial comparisons16
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
1 to 16 of 16
Download this page as JSON| Comparison | Source |
|---|---|
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Non-cardiovascular Death (Including Fatal Bleeding) | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Major Fatal and Non-fatal Bleeding | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Gastrointestinal Bleeding | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Cardiovascular Mortality (Cardiac and Non-cardiac) | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: All-cause Mortality | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Blood Transfusion | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Thrombotic Stroke | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Stent Thrombosis | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Non-cardiovascular Death (Including Fatal Bleeding) and Major Non-fatal Bleeding | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Coronary Revascularisation | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Myocardial Infarction (Fatal and Non-fatal) | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Iron Therapy | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Cardiovascular Death and Non-fatal Myocardial Infarction | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: deaths from any cause | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: Incidence: Intracranial Haemorrhage | Trial comparisons |
| 3 Months Dual Anti-platelet Therapy vs 12 Months Dual Anti-platelet Therapy: serious adverse events | Trial comparisons |
trials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03252249/comparisons